LBPH Projected Dividend Yield
Longboard Pharmaceuticals Inc ( NASDAQ : LBPH )Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing medicines for neurological diseases. Co. is focused on developing the following product candidates: LP352, an oral, centrally acting, 5-hydroxytryptamine 2c receptor subtype, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies; LP659, a centrally acting, sphingosine-1-phosphate receptor subtypes 1 and 5 modulator in preclinical studies for multiple neurological diseases; and LP143, a centrally acting, full cannabinoid type 2 receptor agonist in preclinical studies for central nervous system diseases and disorders. 20 YEAR PERFORMANCE RESULTS |
LBPH Dividend History Detail LBPH Dividend News LBPH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |